{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:30:37Z","timestamp":1791653437770,"version":"4.3.4"},"reference-count":285,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jacbts.2017.07.013","type":"journal-article","created":{"date-parts":[[2017,12,25]],"date-time":"2017-12-25T14:07:29Z","timestamp":1514210849000},"page":"770-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":191,"title":["Murine Models of Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"2","author":[{"given":"Maria","family":"Valero-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Backman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Sam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2017.07.013_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCRESAHA.115.302922","article-title":"Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies","volume":"115","author":"Sharma","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib3","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ejhf.304","article-title":"Heart failure with preserved ejection fraction: uncertainties and dilemmas","volume":"17","author":"Ferrari","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/eurheartj\/ehv561","article-title":"Defining HFpEF: where do we draw the line?","volume":"37","author":"Borlaug","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2017.07.013_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","article-title":"Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap","volume":"134","author":"Shah","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib7","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2017.07.013_bib8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/eurheartj\/eht117","article-title":"Heart failure with preserved and reduced ejection fraction: different risk profiles for different diseases","volume":"34","author":"Borlaug","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2017.07.013_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jacc.2013.10.063","article-title":"Pre-clinical diastolic dysfunction","volume":"63","author":"Wan","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure","volume":"306","author":"Kane","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jacbts.2017.07.013_bib12","first-page":"III78","article-title":"Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure","volume":"81","author":"Packer","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jacc.2013.09.052","article-title":"Impaired systolic function by strain imaging in heart failure with preserved ejection fraction","volume":"63","author":"Kraigher-Krainer","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ejhf.754","article-title":"Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial","volume":"19","author":"DeVore","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/RES.0b013e3182582523","article-title":"Animal models of heart failure: a scientific statement from the American Heart Association","volume":"111","author":"Houser","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib16","doi-asserted-by":"crossref","first-page":"H771","DOI":"10.1152\/ajpheart.00282.2015","article-title":"A\u00a0mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II","volume":"309","author":"Regan","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib17","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cardfail.2014.09.001","article-title":"Murine models of diastolic dysfunction and heart failure with preserved ejection fraction","volume":"20","author":"Horgan","year":"2014","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.116.025795","article-title":"Ejection fraction: misunderstood and overrated (changing the paradigm in categorizing heart failure)","volume":"135","author":"Konstam","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib19","doi-asserted-by":"crossref","first-page":"H88","DOI":"10.1152\/ajpheart.00642.2013","article-title":"Ultrastructural and cellular basis for the development of abnormal myocardial mechanics during the transition from hypertension to heart failure","volume":"306","author":"Shah","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib20","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2013.07.010","article-title":"Matchmaking for the optimization of clinical trials of heart failure with preserved ejection fraction: no laughing matter","volume":"62","author":"Shah","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib21","first-page":"767","article-title":"In\u00a0vivo models for heart failure research","volume":"22","author":"Halapas","year":"2008","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.jacbts.2017.07.013_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1242\/dmm.005017","article-title":"Heart failure and mouse models","volume":"3","author":"Breckenridge","year":"2010","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jacbts.2017.07.013_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10741-012-9305-3","article-title":"Rodent models of heart failure: an updated review","volume":"18","author":"Gomes","year":"2013","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacbts.2017.07.013_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11010-016-2849-0","article-title":"Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research","volume":"424","author":"Rai","year":"2017","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacbts.2017.07.013_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.carpath.2006.09.001","article-title":"Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis","volume":"15","author":"Russell","year":"2006","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.CIR.0000048894.99865.02","article-title":"Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging","volume":"107","author":"Lakatta","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib27","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.0000048893.62841.F7","article-title":"Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease","volume":"107","author":"Lakatta","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tcm.2009.12.004","article-title":"Cardiac aging in mice and humans: the role of mitochondrial oxidative stress","volume":"19","author":"Dai","year":"2009","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacbts.2017.07.013_bib29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10741-011-9273-z","article-title":"Heart failure with preserved ejection fraction in the elderly: scope of the problem","volume":"17","author":"Kaila","year":"2012","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacbts.2017.07.013_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-animal-022114-110829","article-title":"Animal models of aging research: implications for human aging and age-related diseases","volume":"3","author":"Mitchell","year":"2015","journal-title":"Annu Rev Anim Biosci"},{"key":"10.1016\/j.jacbts.2017.07.013_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCRESAHA.115.302929","article-title":"Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium","volume":"115","author":"Loffredo","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib32","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.105.541078","article-title":"Age- and gender-related ventricular-vascular stiffening: a community-based study","volume":"112","author":"Redfield","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib33","first-page":"427","article-title":"Age-associated changes in hearts of male Fischer 344\/Brown Norway F1 rats","volume":"36","author":"Walker","year":"2006","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.jacbts.2017.07.013_bib34","first-page":"H259","article-title":"Morphological and contractile characteristics of rat cardiac myocytes from maturation to senescence","volume":"257","author":"Fraticelli","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1113\/eph8802549","article-title":"Cardiomyocyte death and the ageing and failing heart","volume":"88","author":"Goldspink","year":"2003","journal-title":"Exp Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib36","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/01.RES.68.6.1560","article-title":"Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy","volume":"68","author":"Olivetti","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib37","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2017.07.013_bib38","doi-asserted-by":"crossref","first-page":"B307","DOI":"10.1093\/gerona\/55.6.B307","article-title":"Age effects on the adaptive response of the female rat heart following aortic constriction","volume":"55","author":"Boluyt","year":"2000","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacbts.2017.07.013_bib39","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1152\/japplphysiol.01026.2003","article-title":"Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart","volume":"96","author":"Boluyt","year":"2004","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.CIR.104.2.221","article-title":"Exercise training attenuates age-associated diastolic dysfunction in rats","volume":"104","author":"Brenner","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib41","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/01.CIR.101.18.2185","article-title":"Increased diastolic chamber stiffness during demand ischemia: response to quick length change differentiates rigor-activated from calcium-activated tension","volume":"101","author":"Varma","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib42","doi-asserted-by":"crossref","first-page":"H2132","DOI":"10.1152\/ajpheart.00405.2004","article-title":"Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure","volume":"287","author":"Pacher","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3346\/jkms.2009.24.1.32","article-title":"Long-term exercise training attenuates age-related diastolic dysfunction: association of myocardial collagen cross-linking","volume":"24","author":"Choi","year":"2009","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jacbts.2017.07.013_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0531-5565(96)00078-2","article-title":"Management and design of the maintenance of SAM mouse strains: an animal model for accelerated senescence and age-associated disorders","volume":"32","author":"Hosokawa","year":"1997","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0197-4580(99)00008-1","article-title":"Senescence-accelerated mouse (SAM): a biogerontological resource in aging research","volume":"20","author":"Takeda","year":"1999","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jacbts.2017.07.013_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0531-5565(96)00068-X","article-title":"Pathobiology of the senescence-accelerated mouse (SAM)","volume":"32","author":"Takeda","year":"1997","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0047-6374(81)90084-1","article-title":"A\u00a0new murine model of accelerated senescence","volume":"17","author":"Takeda","year":"1981","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.jacbts.2017.07.013_bib48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11064-009-9922-y","article-title":"Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice","volume":"34","author":"Takeda","year":"2009","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib49","doi-asserted-by":"crossref","first-page":"H824","DOI":"10.1152\/ajpheart.00407.2010","article-title":"Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse","volume":"301","author":"Reed","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib50","first-page":"35","article-title":"The senescence accelerated mouse prone 8 (SAMP8): a novel murine model for cardiac aging","author":"Karuppagounder","year":"2016","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jacbts.2017.07.013_bib51","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/biof.1280","article-title":"Role of MAPK-mediated endoplasmic reticulum stress signaling in the heart during aging in senescence-accelerated prone mice","volume":"42","author":"Sreedhar","year":"2016","journal-title":"Biofactors"},{"key":"10.1016\/j.jacbts.2017.07.013_bib52","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1093\/eurheartj\/ehu389","article-title":"Midlife blood pressure change and left ventricular mass and remodelling in older age in the 1946 British Birth Cohort Study","volume":"35","author":"Ghosh","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2017.07.013_bib53","article-title":"Clinical phenotypes in heart failure with preserved ejection fraction","volume":"5","author":"Samson","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2017.07.013_bib54","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0140-6736(07)60980-5","article-title":"Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial","volume":"369","author":"Solomon","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2017.07.013_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/HYPERTENSIONAHA.109.138529","article-title":"Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction","volume":"55","author":"Solomon","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2017.07.013_bib56","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1152\/japplphysiol.01123.2014","article-title":"High-intensity\u00a0interval training attenuates endothelial dysfunction in a Dahl salt-sensitive rat model of heart failure with preserved ejection fraction","volume":"119","author":"Adams","year":"2015","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib57","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/CIRCULATIONAHA.107.762229","article-title":"Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial","volume":"118","author":"Davis","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib58","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart Disease and Stroke Statistics\u20142017 Update: a report From the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib59","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib60","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","article-title":"Prevalence of resistant hypertension in the United States, 2003\u20132008","volume":"57","author":"Persell","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2017.07.013_bib61","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0008-6363(98)00076-5","article-title":"Rat models of hypertension, cardiac hypertrophy and failure","volume":"39","author":"Doggrell","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib63","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jacbts.2017.07.013_bib64","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cvr\/26.7.671","article-title":"Reactive and reparative myocardial fibrosis in arterial hypertension in the rat","volume":"26","author":"Brilla","year":"1992","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib65","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis","volume":"93","author":"Young","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2017.07.013_bib66","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.amjhyper.2003.10.007","article-title":"Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion","volume":"17","author":"Sam","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacbts.2017.07.013_bib67","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/en.2009-0806","article-title":"Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure","volume":"151","author":"Sam","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.jacbts.2017.07.013_bib68","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCHEARTFAILURE.114.001279","article-title":"Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction","volume":"7","author":"Tanaka","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib69","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurjhf\/hft100","article-title":"Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial","volume":"15","author":"Girerd","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib70","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002724","article-title":"Heart failure with preserved ejection fraction induces beiging in adipose tissue","volume":"9","author":"Valero-Munoz","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib71","doi-asserted-by":"crossref","first-page":"H587","DOI":"10.1152\/ajpheart.00298.2012","article-title":"Interferon-gamma ablation exacerbates myocardial hypertrophy in diastolic heart failure","volume":"303","author":"Garcia","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib72","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/HYPERTENSIONAHA.109.134932","article-title":"Effects of fixed-dose isosorbide dinitrate\/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure","volume":"54","author":"Wilson","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2017.07.013_bib73","first-page":"207","article-title":"Follistatin like 1 regulates hypertrophy in heart failure with preserved ejection fraction","volume":"1","author":"Tanaka","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Basic Trans Sci"},{"key":"10.1016\/j.jacbts.2017.07.013_bib74","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003381","article-title":"Dual endothelin-A\/endothelin-B receptor blockade and cardiac remodeling in heart failure with preserved ejection fraction","volume":"9","author":"Valero-Munoz","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib75","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin","volume":"131","author":"Zile","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib76","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/CIRCULATIONAHA.113.003437","article-title":"Myocardial titin and collagen in cardiac diastolic dysfunction: partners in crime","volume":"128","author":"Hamdani","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib77","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.yjmcc.2011.10.002","article-title":"Getting to the heart of cardiac remodeling; how collagen subtypes may contribute to phenotype","volume":"52","author":"Collier","year":"2012","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib78","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.CIR.0000155257.33485.6D","article-title":"Cardiomyocyte stiffness in diastolic heart failure","volume":"111","author":"Borbely","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib79","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib80","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low myocardial protein kinase G activity in heart failure with preserved ejection fraction","volume":"126","author":"van Heerebeek","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib81","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/HYPERTENSIONAHA.111.183913","article-title":"Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and beta-receptor blockade","volume":"59","author":"Becher","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2017.07.013_bib82","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/j.jacc.2014.02.572","article-title":"Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through proinflammatory effects and endothelial-mesenchymal transition","volume":"63","author":"Murdoch","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib83","doi-asserted-by":"crossref","first-page":"H339","DOI":"10.1152\/ajpheart.00742.2014","article-title":"Cardiac steatosis potentiates angiotensin II effects in the heart","volume":"308","author":"Glenn","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib84","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.104.3.346","article-title":"Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension","volume":"104","author":"Ichihara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib85","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajpath.2015.09.010","article-title":"Granzyme B deficiency protects against angiotensin ii-induced cardiac fibrosis","volume":"186","author":"Shen","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib86","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/gtc.12055","article-title":"Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16","volume":"18","author":"Matsumoto","year":"2013","journal-title":"Genes Cells"},{"key":"10.1016\/j.jacbts.2017.07.013_bib87","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fphys.2014.00396","article-title":"Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation","volume":"5","author":"Gomolak","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068697","article-title":"Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes","volume":"8","author":"Essick","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacbts.2017.07.013_bib89","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1113\/expphysiol.2011.057612","article-title":"Angiotensin II-induced dilated cardiomyopathy in Balb\/c but not C57BL\/6J mice","volume":"96","author":"Peng","year":"2011","journal-title":"Exp Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib90","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/FJC.0b013e31815bb629","article-title":"Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice","volume":"51","author":"Xu","year":"2008","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib91","doi-asserted-by":"crossref","first-page":"H1103","DOI":"10.1152\/ajpheart.00636.2012","article-title":"ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4","volume":"304","author":"Mori","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib92","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00395-012-0308-y","article-title":"Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in\u00a0vivo","volume":"107","author":"Westermann","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib93","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1113\/expphysiol.2014.084095","article-title":"Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle","volume":"100","author":"Kadoguchi","year":"2015","journal-title":"Exp Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib94","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1126\/science.2563177","article-title":"A\u00a0genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure","volume":"243","author":"Rapp","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jacbts.2017.07.013_bib95","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004872-200018010-00016","article-title":"Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats","volume":"18","author":"Doi","year":"2000","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacbts.2017.07.013_bib96","first-page":"H2471","article-title":"Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats","volume":"267","author":"Inoko","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib97","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/eurheartj\/ehr106","article-title":"Ca2+ entry mode of Na+\/Ca2+ exchanger as a new therapeutic target for heart failure with preserved ejection fraction","volume":"33","author":"Kamimura","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2017.07.013_bib98","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1097\/HJH.0b013e3283569c5a","article-title":"L-Carnitine prevents the development of ventricular fibrosis and heart failure with preserved ejection fraction in hypertensive heart disease","volume":"30","author":"Omori","year":"2012","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacbts.2017.07.013_bib99","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijcard.2014.11.106","article-title":"Heart failure with preserved ejection fraction: refocusing on diastole","volume":"179","author":"Abbate","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib100","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCHEARTFAILURE.111.966366","article-title":"Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction","volume":"5","author":"Dunlay","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib101","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.27.3.481","article-title":"Salt sensitivity of blood pressure in humans","volume":"27","author":"Weinberger","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2017.07.013_bib102","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/HYPERTENSIONAHA.112.202705","article-title":"Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction","volume":"60","author":"Hummel","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2017.07.013_bib103","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12471-016-0815-9","article-title":"Animal models of heart failure with preserved ejection fraction","volume":"24","author":"Conceicao","year":"2016","journal-title":"Neth Heart J"},{"key":"10.1016\/j.jacbts.2017.07.013_bib104","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.2042-7158.1969.tb08280.x","article-title":"A\u00a0model for evaluation of thiazide-induced hypotension","volume":"21","author":"Willard","year":"1969","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib105","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.jacc.2003.11.043","volume":"43","author":"Ogata","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib106","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/sj.bjp.0703157","article-title":"Enhanced blood pressure sensitivity to DOCA-salt treatment in endothelin ET(B) receptor\u2013deficient rats","volume":"129","author":"Matsumura","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib107","doi-asserted-by":"crossref","first-page":"H2417","DOI":"10.1152\/ajpheart.01170.2005","article-title":"Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension","volume":"290","author":"Grobe","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib108","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.bjp.0706384","article-title":"Reversal of cardiac dysfunction by selective ET-A receptor antagonism","volume":"146","author":"Allan","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib109","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCRESAHA.111.258251","article-title":"Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity","volume":"110","author":"Lovelock","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib110","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCULATIONAHA.109.915215","article-title":"Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via \u201cnongenomic effects.\u201d","volume":"122","author":"Mohammed","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib111","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/CIRCULATIONAHA.109.883777","article-title":"Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction","volume":"121","author":"Silberman","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib112","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yjmcc.2012.12.003","article-title":"Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties","volume":"56","author":"Jeong","year":"2013","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib113","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1096\/fj.201600672r","article-title":"High-intensity interval training prevents oxidant-mediated diaphragm muscle weakness in hypertensive mice","volume":"31","author":"Bowen","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.jacbts.2017.07.013_bib114","first-page":"227","article-title":"Spontaneous hypertension in rats","volume":"7","author":"Okamoto","year":"1969","journal-title":"Int Rev Exp Pathol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1253\/jcj.27.282","article-title":"Development of a strain of spontaneously hypertensive rats","volume":"27","author":"Okamoto","year":"1963","journal-title":"Jpn Circ J"},{"issue":"suppl 1","key":"10.1016\/j.jacbts.2017.07.013_bib116","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199312001-00002","article-title":"Early structural changes in hypertension: pathophysiology and clinical consequences","volume":"22","author":"Folkow","year":"1993","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib117","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.HYP.19.5.428","article-title":"Genetic variation in hypertensive and \u201ccontrol\u201d strains. What are we controlling for anyway?","volume":"19","author":"Lindpaintner","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2017.07.013_bib118","doi-asserted-by":"crossref","first-page":"H1775","DOI":"10.1152\/ajpheart.00305.2002","article-title":"Structural, functional, and molecular characterization of the SHHF model of heart failure","volume":"283","author":"Heyen","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib119","first-page":"H461","article-title":"Cardiac function and morphology with aging in the spontaneously hypertensive rat","volume":"237","author":"Pfeffer","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib120","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ijcard.2012.03.063","article-title":"Heart failure-induced skeletal myopathy in spontaneously hypertensive rats","volume":"167","author":"Damatto","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib121","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2828(08)80035-1","article-title":"The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure","volume":"27","author":"Bing","year":"1995","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib122","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/00004872-200309000-00023","article-title":"Expression of bradykinin receptors in the left ventricles of rats with pressure overload hypertrophy and heart failure","volume":"21","author":"Kuoppala","year":"2003","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacbts.2017.07.013_bib123","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1073\/pnas.88.18.8277","article-title":"Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in\u00a0vivo murine model of cardiac hypertrophy","volume":"88","author":"Rockman","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2017.07.013_bib124","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.yjmcc.2016.10.011","article-title":"Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload","volume":"101","author":"Beetz","year":"2016","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib125","doi-asserted-by":"crossref","first-page":"9840","DOI":"10.1074\/jbc.M110.197079","article-title":"Cardiac myocyte-specific ablation of follistatin-like 3 attenuates stress-induced myocardial hypertrophy","volume":"286","author":"Shimano","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2017.07.013_bib126","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.amjhyper.2004.08.034","article-title":"Heart failure after long-term supravalvular aortic constriction in rats","volume":"18","author":"Boluyt","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacbts.2017.07.013_bib127","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cardiores.2005.04.018","article-title":"Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism","volume":"67","author":"Liao","year":"2005","journal-title":"Cardiovasc Res"},{"issue":"45","key":"10.1016\/j.jacbts.2017.07.013_bib128","doi-asserted-by":"crossref","first-page":"E7116","DOI":"10.1073\/pnas.1607728113","article-title":"PDE1C deficiency antagonizes pathological cardiac remodeling and dysfunction","volume":"113","author":"Knight","year":"2016","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"10.1016\/j.jacbts.2017.07.013_bib129","doi-asserted-by":"crossref","first-page":"34036","DOI":"10.1038\/srep34036","article-title":"Histone deacetylase inhibitor phenylbutyrate exaggerates heart failure in pressure overloaded mice independently of HDAC inhibition","volume":"6","author":"Ma","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2017.07.013_bib130","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1172\/JCI25397","article-title":"Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction","volume":"116","author":"Perrino","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2017.07.013_bib131","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fphys.2013.00205","article-title":"Temporal and morphological impact of pressure overload in transgenic FHC mice","volume":"4","author":"Chen","year":"2013","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib132","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","article-title":"Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss","volume":"53","author":"Lavie","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib133","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jcmg.2009.10.012","article-title":"The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"3","author":"Turkbey","year":"2010","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacbts.2017.07.013_bib134","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","article-title":"Body\u00a0mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in\u00a0Heart Failure with Preserved Ejection Fraction (I-PRESERVE)\u00a0trial","volume":"4","author":"Haass","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib135","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.amjcard.2013.12.031","article-title":"Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction","volume":"113","author":"Haykowsky","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib136","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3945\/ajcn.112.047860","article-title":"Associations between body composition and gait-speed decline: results from the Health, Aging, and Body Composition study","volume":"97","author":"Beavers","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacbts.2017.07.013_bib137","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13668-015-0123-9","article-title":"Caloric restriction for treatment of geriatric obesity: do the benefits outweigh the risks?","volume":"4","author":"Normandin","year":"2015","journal-title":"Curr Nutr Rep"},{"key":"10.1016\/j.jacbts.2017.07.013_bib138","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/jama.1995.03530240025035","article-title":"Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial","volume":"274","author":"Katzel","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jacbts.2017.07.013_bib139","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2016.05.019","article-title":"The HFpEF obesity phenotype: the elephant in the room","volume":"68","author":"Kitzman","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib140","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.jacc.2009.07.054","article-title":"Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function","volume":"54","author":"de las Fuentes","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib141","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/HJH.0b013e3280115bfb","article-title":"Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study","volume":"25","author":"Ikonomidis","year":"2007","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacbts.2017.07.013_bib142","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.clinthera.2015.08.005","article-title":"Management of heart failure with preserved ejection fraction: a review","volume":"37","author":"Nanayakkara","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.jacbts.2017.07.013_bib143","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ejhf.600","article-title":"Reframing the association and significance of co-morbidities in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib144","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2017.07.013_bib145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11897-016-0298-4","article-title":"Cardiometabolic syndrome and increased risk of heart failure","volume":"13","author":"von Bibra","year":"2016","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacbts.2017.07.013_bib146","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib147","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","article-title":"Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction","volume":"64","author":"Mentz","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib148","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hfc.2012.06.005","article-title":"Insulin resistance and heart failure: molecular mechanisms","volume":"8","author":"Aroor","year":"2012","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jacbts.2017.07.013_bib149","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/ejhf.317","article-title":"Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction","volume":"17","author":"Scherbakov","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib150","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehm361","article-title":"Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy","volume":"28","author":"Konduracka","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2017.07.013_bib151","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81294-5","article-title":"Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db\/db mice","volume":"84","author":"Chen","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jacbts.2017.07.013_bib152","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1093\/eurheartj\/ehs218","article-title":"Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction","volume":"34","author":"Reil","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2017.07.013_bib153","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1172\/JCI10761","article-title":"Interactions between insulin resistance and insulin secretion in the development of glucose intolerance","volume":"106","author":"Cavaghan","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2017.07.013_bib154","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1189\/jlb.0213075","article-title":"Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macrophage polarization","volume":"95","author":"Cucak","year":"2014","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib155","doi-asserted-by":"crossref","first-page":"E1104","DOI":"10.1152\/ajpendo.2000.279.5.E1104","article-title":"Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db\/db) mice","volume":"279","author":"Belke","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacbts.2017.07.013_bib156","doi-asserted-by":"crossref","first-page":"H976","DOI":"10.1152\/ajpheart.00088.2002","article-title":"Echocardiographic assessment of cardiac function in diabetic db\/db and transgenic db\/db-hGLUT4 mice","volume":"283","author":"Semeniuk","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib157","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diabetes.52.2.434","article-title":"Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db\/db mice","volume":"52","author":"Aasum","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jacbts.2017.07.013_bib158","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.CIR.0000083716.82622.FD","article-title":"Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice","volume":"108","author":"Barouch","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib159","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ejheart.2006.03.001","article-title":"Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions","volume":"8","author":"Van den Bergh","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib160","first-page":"460","article-title":"Primary myocardial disease in the diabetic mouse. An ultrastructural study","volume":"40","author":"Giacomelli","year":"1979","journal-title":"Lab Invest"},{"key":"10.1016\/j.jacbts.2017.07.013_bib161","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00125-014-3201-4","article-title":"Treatment with brain natriuretic peptide prevents the development of cardiac dysfunction in obese diabetic db\/db mice","volume":"57","author":"Plante","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacbts.2017.07.013_bib162","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCHEARTFAILURE.113.000672","article-title":"Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db\/db mice by reducing lipotoxicity and inflammation","volume":"7","author":"Mori","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib163","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvu223","article-title":"Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4","volume":"104","author":"Hamdani","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib164","doi-asserted-by":"crossref","first-page":"E592","DOI":"10.1152\/ajpendo.00277.2013","article-title":"Effects of insulin resistance on skeletal muscle growth and exercise capacity in type 2 diabetic mouse models","volume":"306","author":"Ostler","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacbts.2017.07.013_bib165","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.phrs.2016.02.026","article-title":"Long-term administration of angiotensin (1-7) prevents heart and lung dysfunction in a mouse model of type 2 diabetes (db\/db) by reducing oxidative stress, inflammation and pathological remodeling","volume":"107","author":"Papinska","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib166","doi-asserted-by":"crossref","first-page":"736860","DOI":"10.5402\/2012\/736860","article-title":"Downregulation in GATA4 and downstream structural and contractile genes in the db\/db mouse heart","volume":"2012","author":"Broderick","year":"2012","journal-title":"ISRN Endocrinol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib167","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.0000112582.16683.EA","article-title":"Impact of\u00a0obesity on plasma natriuretic peptide levels","volume":"109","author":"Wang","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib168","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/oxfordjournals.jhered.a106073","article-title":"Obese, a new mutation in the house mouse","volume":"41","author":"Ingalls","year":"1950","journal-title":"J\u00a0Hered"},{"key":"10.1016\/j.jacbts.2017.07.013_bib169","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1100\/tsw.2007.117","article-title":"The physiology of obese-hyperglycemic mice [ob\/ob mice]","volume":"7","author":"Lindstrom","year":"2007","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.jacbts.2017.07.013_bib170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01219435","article-title":"Development of the obese-hyperglycaemic syndrome in mice","volume":"4","author":"Westman","year":"1968","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacbts.2017.07.013_bib171","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/0026-0495(95)90244-9","article-title":"Development of insulin secretory function in young obese hyperglycemic mice (Ume\u00e5 ob\/ob)","volume":"44","author":"Edvell","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.jacbts.2017.07.013_bib172","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1210\/endo.140.2.6514","article-title":"Initiation of increased pancreatic islet growth in young normoglycemic mice (Ume\u00e5\u00a0+\/?)","volume":"140","author":"Edvell","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.jacbts.2017.07.013_bib173","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/BF01212241","article-title":"Differences in the development of the obese-hyperglycemic syndrome in obob and NZO mice","volume":"6","author":"Herberg","year":"1970","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacbts.2017.07.013_bib174","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-201X.1968.tb10814.x","article-title":"Glucose tolerance in the period preceding the appearance of the manifest obese-hyperglycemic syndrome in mice","volume":"72","author":"Danielsson","year":"1968","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.jacbts.2017.07.013_bib175","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jcp.24231","article-title":"Effects of acute exercise over heart proteome from monogenic obese (ob\/ob) mice","volume":"228","author":"Petriz","year":"2013","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib176","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1677\/joe.1.06241","article-title":"Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob\/ob obese mice","volume":"188","author":"Dong","year":"2006","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib177","doi-asserted-by":"crossref","first-page":"560","DOI":"10.4161\/cc.7.5.5529","article-title":"Decreased p110alpha catalytic activity accompanies increased myocyte apoptosis and cardiac hypertrophy in leptin deficient ob\/ob mice","volume":"7","author":"Trivedi","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jacbts.2017.07.013_bib178","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1210\/en.2003-0242","article-title":"Cardiac lipid accumulation associated with diastolic dysfunction in obese mice","volume":"144","author":"Christoffersen","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.jacbts.2017.07.013_bib179","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1097\/00004872-199917121-00026","article-title":"Contrasting blood pressure effects of obesity in leptin-deficient ob\/ob mice and agouti yellow obese mice","volume":"17","author":"Mark","year":"1999","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacbts.2017.07.013_bib180","doi-asserted-by":"crossref","first-page":"H2473","DOI":"10.1152\/ajpheart.2001.281.6.H2473","article-title":"Altered leptin signaling is sufficient, but not required, for hypotension associated with caloric restriction","volume":"281","author":"Swoap","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib181","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1139\/apnm-2014-0005","article-title":"All-trans retinoic acid stimulates gene expression of the cardioprotective natriuretic peptide system and prevents fibrosis and apoptosis in cardiomyocytes of obese ob\/ob mice","volume":"39","author":"Manolescu","year":"2014","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.jacbts.2017.07.013_bib182","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/ATVBAHA.112.300036","article-title":"Increased aortic stiffness and attenuated lysyl oxidase activity in obesity","volume":"33","author":"Chen","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib183","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2362.2006.01596.x","article-title":"Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice","volume":"36","author":"Christoffersen","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacbts.2017.07.013_bib184","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.regpep.2013.12.005","article-title":"Unexpected effects of voluntary exercise training on natriuretic peptide and receptor mRNA expression in the ob\/ob mouse heart","volume":"188","author":"Broderick","year":"2014","journal-title":"Regul Pept"},{"key":"10.1016\/j.jacbts.2017.07.013_bib185","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.7624776","article-title":"Effects of the obese gene product on body weight regulation in ob\/ob mice","volume":"269","author":"Pelleymounter","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jacbts.2017.07.013_bib186","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.RES.0000199348.10580.1d","article-title":"Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity","volume":"98","author":"Barouch","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib187","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/physrev.00017.2007","article-title":"Cardiac remodeling in obesity","volume":"88","author":"Abel","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jacbts.2017.07.013_bib188","first-page":"608","article-title":"Genetics of human obesity","volume":"329","author":"Clement","year":"2006","journal-title":"C\u00a0R Biol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib189","first-page":"91","article-title":"Studies on the diabetogenic action of streptozotocin (NSC-37917)","volume":"29","author":"Rakieten","year":"1963","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.jacbts.2017.07.013_bib190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3181\/00379727-126-32401","article-title":"Studies of the diabetogenic action of streptozotocin","volume":"126","author":"Junod","year":"1967","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.jacbts.2017.07.013_bib191","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1444-2892.2003.00160.x","article-title":"The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes","volume":"12","author":"Wei","year":"2003","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacbts.2017.07.013_bib192","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1196\/annals.1372.025","article-title":"Alterations in atrial natriuretic peptide and its receptor levels in long-term, streptozotocin-induced, diabetes in rats","volume":"1084","author":"Obineche","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jacbts.2017.07.013_bib193","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11010-016-2767-1","article-title":"Cardioprotective effects of rutin via alteration in TNF-alpha, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats","volume":"420","author":"Saklani","year":"2016","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacbts.2017.07.013_bib194","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12906-015-0817-y","article-title":"Esculin improves dyslipidemia, inflammation and renal damage in streptozotocin-induced diabetic rats","volume":"15","author":"Wang","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.jacbts.2017.07.013_bib195","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/01.RES.47.6.922","article-title":"Altered myocardial mechanics in diabetic rats","volume":"47","author":"Fein","year":"1980","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib196","first-page":"H900","article-title":"Hemodynamic alterations in chronically conscious unrestrained diabetic rats","volume":"252","author":"Carbonell","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib197","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0024-3205(01)01141-9","article-title":"Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model","volume":"69","author":"Mihm","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.jacbts.2017.07.013_bib198","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bjp.0704131","article-title":"Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats","volume":"133","author":"Miric","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib199","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/aps.2011.54","article-title":"Involvement of RhoA\/ROCK in myocardial fibrosis in a rat model of type 2 diabetes","volume":"32","author":"Zhou","year":"2011","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jacbts.2017.07.013_bib200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bcp.2015.03.009","article-title":"Treatment with angiotensin-(1-9) alleviates the cardiomyopathy in streptozotocin-induced diabetic rats","volume":"95","author":"Zheng","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib201","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.yjmcc.2010.02.012","article-title":"Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy","volume":"48","author":"Kruger","year":"2010","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib202","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1111\/bph.12656","article-title":"Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis","volume":"171","author":"Satheesan","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib203","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00395-011-0184-x","article-title":"Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload","volume":"106","author":"Falcao-Pires","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib204","first-page":"527090","article-title":"Treadmill exercise preconditioning attenuates lung damage caused by systemic endotoxemia in type 1 diabetic rats","volume":"2013","author":"Hung","year":"2013","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib205","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cardiores.2007.06.022","article-title":"Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat","volume":"76","author":"Connelly","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib206","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.RES.0000207406.94146.c2","article-title":"Diabetic cardiomyopathy: the search for a unifying hypothesis","volume":"98","author":"Poornima","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib207","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/labinvest.3780057","article-title":"Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent","volume":"80","author":"Fiordaliso","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.jacbts.2017.07.013_bib208","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1006\/jmcc.2000.1139","article-title":"Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction","volume":"32","author":"Depre","year":"2000","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib209","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1475-2840-11-105","article-title":"Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats","volume":"11","author":"Lu","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.phrs.2009.01.003","article-title":"The direct effects of streptozotocin and alloxan on contractile function in rat heart","volume":"59","author":"Salem","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib211","doi-asserted-by":"crossref","first-page":"R1787","DOI":"10.1152\/ajpregu.00059.2007","article-title":"Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes","volume":"293","author":"Lacombe","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib212","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0735-1097(99)00436-2","article-title":"Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway","volume":"34","author":"Joffe","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib213","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1043-6618(03)00191-9","article-title":"Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats","volume":"48","author":"Akula","year":"2003","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib214","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00001573-199711000-00008","article-title":"Dobutamine echocardiography versus nuclear cardiac imaging for evaluation of myocardial viability","volume":"12","author":"Nagueh","year":"1997","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib215","doi-asserted-by":"crossref","first-page":"H1489","DOI":"10.1152\/ajpheart.00278.2006","article-title":"Role of changes in cardiac metabolism in development of diabetic cardiomyopathy","volume":"291","author":"An","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib216","first-page":"275","article-title":"Fatty, a new mutation in the rats","volume":"52","author":"Zucker","year":"1961","journal-title":"J\u00a0Heredity"},{"key":"10.1016\/j.jacbts.2017.07.013_bib217","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1152\/ajplegacy.1972.223.1.176","article-title":"Studies on food intake of genetically obese rats","volume":"223","author":"Bray","year":"1972","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10741-013-9387-6","article-title":"Animal models of insulin resistance and heart failure","volume":"19","author":"Velez","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacbts.2017.07.013_bib219","doi-asserted-by":"crossref","first-page":"H1708","DOI":"10.1152\/ajpheart.2000.279.4.H1708","article-title":"Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats","volume":"279","author":"Ren","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib220","doi-asserted-by":"crossref","first-page":"R793","DOI":"10.1152\/ajpregu.00521.2002","article-title":"High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats","volume":"286","author":"Conti","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib221","doi-asserted-by":"crossref","first-page":"H2102","DOI":"10.1152\/ajpheart.00935.2004","article-title":"Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats","volume":"288","author":"Wang","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib222","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1475-2840-9-25","article-title":"Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle","volume":"9","author":"van den Brom","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib223","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1054-8807(03)00109-1","article-title":"Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats","volume":"13","author":"Fredersdorf","year":"2004","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib224","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.amjhyper.2003.10.006","article-title":"Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats","volume":"17","author":"Toblli","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacbts.2017.07.013_bib225","first-page":"29","article-title":"Rat models of the metabolic syndrome","volume":"86","author":"Tofovic","year":"2003","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.jacbts.2017.07.013_bib226","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1081\/JDI-100100882","article-title":"Renal function and structure in diabetic, hypertensive, obese ZDFxSHHF-hybrid rats","volume":"22","author":"Tofovic","year":"2000","journal-title":"Ren Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib227","doi-asserted-by":"crossref","first-page":"F1605","DOI":"10.1152\/ajprenal.00511.2006","article-title":"Dynamic blood pressure load and nephropathy in the ZSF1 (fa\/fa cp) model of type 2 diabetes","volume":"293","author":"Griffin","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib228","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/CIRCHEARTFAILURE.113.000539","article-title":"Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model","volume":"6","author":"Hamdani","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib229","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002760","article-title":"Distinct endothelial cell responses in the heart and kidney microvasculature characterize the progression of heart failure with preserved ejection fraction in the obese ZSF1 rat with cardiorenal metabolic syndrome","volume":"9","author":"van Dijk","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib230","doi-asserted-by":"crossref","first-page":"751513","DOI":"10.4061\/2011\/751513","article-title":"TRC120038, a novel dual AT(1)\/ET(A) receptor blocker for control of hypertension, diabetic nephropathy, and cardiomyopathy in ob-ZSF1 Rats","volume":"2011","author":"Mohanan","year":"2011","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.jacbts.2017.07.013_bib231","doi-asserted-by":"crossref","first-page":"H1556","DOI":"10.1152\/ajpheart.00076.2015","article-title":"Echocardiography and invasive hemodynamics during stress testing for diagnosis of heart failure with preserved ejection fraction: an experimental study","volume":"308","author":"Leite","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib232","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","article-title":"Myocardial structure and function differ in systolic and diastolic heart failure","volume":"113","author":"van Heerebeek","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib233","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/CIRCRESAHA.108.193326","article-title":"Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium","volume":"104","author":"Borbely","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib234","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.115.018935","article-title":"SIRT3-AMP-activated protein kinase activation by nitrite and metformin improves hyperglycemia and normalizes pulmonary hypertension associated with heart failure with preserved ejection fraction","volume":"133","author":"Lai","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib235","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib236","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jacc.2015.06.1314","article-title":"Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands","volume":"66","author":"Vermond","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib237","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.jacc.2016.08.048","article-title":"Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins","volume":"68","author":"Kotecha","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib238","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.CIR.74.5.1075","article-title":"Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure","volume":"74","author":"Armstrong","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib239","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.CIR.75.4.857","article-title":"Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects","volume":"75","author":"Wilson","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib240","first-page":"1","article-title":"History of arrhythmias","author":"Janse","year":"2006","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib241","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.RES.85.2.174","article-title":"Reentry and fibrillation in the mouse heart. A challenge to the critical mass hypothesis","volume":"85","author":"Vaidya","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib242","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1161\/01.CIR.94.10.2641","article-title":"In\u00a0vivo cardiac electrophysiology studies in the mouse","volume":"94","author":"Berul","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib243","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1161\/01.CIR.99.11.1508","article-title":"Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation","volume":"99","author":"Hagendorff","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib244","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s003950200052","article-title":"Induction of atrial fibrillation in mice by rapid transesophageal atrial pacing","volume":"97","author":"Schrickel","year":"2002","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib245","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fphys.2012.00296","article-title":"An introduction to murine models of atrial fibrillation","volume":"3","author":"Riley","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib246","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/europace\/eup328","article-title":"Animal models for atrial fibrillation: clinical insights and scientific opportunities","volume":"12","author":"Nishida","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jacbts.2017.07.013_bib247","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCHEARTFAILURE.110.958801","article-title":"Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction","volume":"4","author":"Thenappan","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib248","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","article-title":"Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure","volume":"37","author":"Ghio","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib249","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-8703(07)80038-X","article-title":"Diastolic left ventricular dysfunction leading to severe reversible pulmonary hypertension","volume":"126","author":"Kessler","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacbts.2017.07.013_bib250","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCULATIONAHA.111.038885","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a target for therapy?","volume":"124","author":"Waxman","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib251","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/CIRCHEARTFAILURE.113.000823","article-title":"Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives","volume":"7","author":"Guazzi","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib252","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/674770","article-title":"A\u00a0comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?","volume":"3","author":"Maarman","year":"2013","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jacbts.2017.07.013_bib253","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1161\/01.CIR.0000042762.47822.FE","article-title":"Cardiology patient page. Pulmonary hypertension","volume":"106","author":"Benisty","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib254","first-page":"1","article-title":"The rat is a poor animal model for the study of human pulmonary hypertension","volume":"3","author":"Heath","year":"1992","journal-title":"Cardioscience"},{"key":"10.1016\/j.jacbts.2017.07.013_bib255","first-page":"542","article-title":"New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension","volume":"57","author":"Hislop","year":"1976","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib256","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/hc0202.101974","article-title":"Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels","volume":"105","author":"Michelakis","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib257","first-page":"L1126","article-title":"Atrial natriuretic peptide accounts for increased cGMP in hypoxia-induced hypertensive rat lungs","volume":"272","author":"Muramatsu","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib258","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.healun.2011.03.010","article-title":"Bosentan attenuates right ventricular hypertrophy and fibrosis in normobaric hypoxia model of pulmonary hypertension","volume":"30","author":"Choudhary","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacbts.2017.07.013_bib259","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1073\/pnas.1120385109","article-title":"Digoxin inhibits development of hypoxic pulmonary hypertension in mice","volume":"109","author":"Abud","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2017.07.013_bib260","doi-asserted-by":"crossref","first-page":"L1013","DOI":"10.1152\/ajplung.00217.2009","article-title":"Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure","volume":"297","author":"Stenmark","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib261","first-page":"H818","article-title":"Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features","volume":"236","author":"Rabinovitch","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib262","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2353\/ajpath.2009.080345","article-title":"Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia","volume":"174","author":"Dempsey","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib263","doi-asserted-by":"crossref","first-page":"L422","DOI":"10.1152\/ajplung.90293.2008","article-title":"Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling","volume":"295","author":"Nozik-Grayck","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib264","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCRESAHA.108.182014","article-title":"Interleukin-6 overexpression induces pulmonary hypertension","volume":"104","author":"Steiner","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.07.013_bib265","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1172\/JCI11144","article-title":"Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?","volume":"106","author":"Voelkel","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2017.07.013_bib266","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/678471","article-title":"Pulmonary hypertension caused by pulmonary venous hypertension","volume":"4","author":"Kulik","year":"2014","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jacbts.2017.07.013_bib267","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01851776","article-title":"Response of the left ventricular connective tissue to hypoxia","volume":"183","author":"Genovese","year":"1983","journal-title":"Res Exp Med (Berl)"},{"key":"10.1016\/j.jacbts.2017.07.013_bib268","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature20173","article-title":"Hypoxia induces heart regeneration in adult mice","volume":"541","author":"Nakada","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2017.07.013_bib269","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/CIRCULATIONAHA.116.022249","article-title":"Heart failure with preserved ejection fraction: a kidney disorder?","volume":"134","author":"Fang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.07.013_bib270","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation","volume":"18","author":"Ter Maaten","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib271","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ejhf.461","article-title":"Renal dysfunction in heart failure with a preserved ejection fraction: cause or consequence?","volume":"18","author":"Ter Maaten","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2017.07.013_bib272","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fimmu.2015.00465","article-title":"Animal models to study links between cardiovascular disease and renal failure and their relevance to human pathology","volume":"6","author":"Hewitson","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib273","doi-asserted-by":"crossref","first-page":"F1253","DOI":"10.1152\/ajprenal.00392.2012","article-title":"Target organ cross talk in cardiorenal syndrome: animal models","volume":"303","author":"Bongartz","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib274","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-59745-352-3_4","article-title":"Small animal models of kidney disease: a review","volume":"466","author":"Hewitson","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib275","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ki.1985.197","article-title":"Myocardial hypertrophy in rats with renal insufficiency","volume":"28","author":"Rambausek","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacbts.2017.07.013_bib276","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ki.1996.444","article-title":"Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis","volume":"50","author":"Stefanski","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacbts.2017.07.013_bib277","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041281","article-title":"Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate","volume":"7","author":"Lekawanvijit","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacbts.2017.07.013_bib278","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000168817","article-title":"Prevention of cardiac hypertrophy in experimental chronic renal failure by long-term ACE inhibitor administration: potential role of lysosomal proteinases","volume":"15","author":"Suzuki","year":"1995","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib279","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.HYP.0000202594.82271.92","article-title":"Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy","volume":"47","author":"Kennedy","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2017.07.013_bib280","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.1992.390","article-title":"Reduced capillary density in the myocardium of uremic rats\u2014a stereological study","volume":"42","author":"Amann","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacbts.2017.07.013_bib281","doi-asserted-by":"crossref","first-page":"R815","DOI":"10.1152\/ajpregu.00727.2009","article-title":"Transient nitric oxide reduction induces permanent cardiac systolic dysfunction and worsens kidney damage in rats with chronic kidney disease","volume":"298","author":"Bongartz","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib282","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/ki.2013.473","article-title":"Chronic kidney disease reduces muscle mitochondria and exercise endurance and its exacerbation by dietary protein through inactivation of pyruvate dehydrogenase","volume":"85","author":"Tamaki","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacbts.2017.07.013_bib283","doi-asserted-by":"crossref","first-page":"2538263","DOI":"10.1155\/2016\/2538263","article-title":"Experimental heart failure models and their pathophysiological characterization","volume":"2016","author":"Becher","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jacbts.2017.07.013_bib284","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1165\/rcmb.2016-0177OC","article-title":"Development of a mouse model of metabolic syndrome, pulmonary hypertension, and heart failure with preserved ejection fraction","volume":"56","author":"Meng","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jacbts.2017.07.013_bib285","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1242\/dmm.024547","article-title":"Using the mouse to model human disease: increasing validity and reproducibility","volume":"9","author":"Justice","year":"2016","journal-title":"Dis Model Mech"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X17302164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X17302164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:20:14Z","timestamp":1762820414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X17302164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":285,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2452302X17302164"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2017.07.013","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Murine Models of Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2017.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}